News - Daptomycin
Infectious diseases specialists from Austin Health are working closely with Microbiologists from the University of Melbourne to understand how Staph is becoming resistant to all antibiotic therapies.
An analysis of the genome of a superbug has yielded crucial, novel information that could aid efforts to counteract the bacterium’s resistance to an antibiotic of last resort.
Hospitals struggle to prevent the infections that complicate treatment for cancer, joint replacement, heart surgery and other conditions.
DALLAS, June 27, 2011 /PRNewswire/ -- ReportsnReports announces it will carry 'Daptomycin - Comprehensive patent search'Report in its store Browse the complete 'Daptomycin - Comprehensive patent search [http://www.reportsnreports.com/reports/90113-daptomycin-comprehensive-patent-search.html ] 'Report now! Search 75000+ Market Research Reports [http://www.reportsnreports.com ] Browse All Pharmaceutical Market Research Reports [http://www.reportsnreports.com/market-research/pharmaceuticals ] Report Summary Eliminate unnecessary risk with the industry benchmark in comprehensive patent information. Pipeline Developer is a regularly updated, professional patent search performed by GenericsWeb's expert team, which not only identifies relevant patents, but delivers categorization and interpretation, all delivered by a convenient online interface. The Pipeline Developer report covers 'Daptomycin [http://www.reportsnreports.com/r
LEXINGTON, Mass., June 16, 2011 /PRNewswire-USNewswire/ -- Cubist Pharmaceuticals, Inc. today praised Rep. Phil Gingrey, R-Ga., and co-sponsors for introducing the Generating Antibiotic Incentives Now (GAIN) Bill of 2011.
